STRATA CRITICAL MEDICAL, INC. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for the quarter ending 2026-06-30 was $4.27M.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for the quarter ending 2025-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for the quarter ending 2025-09-30 was $8.41M.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for the quarter ending 2024-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for fiscal 2025 was $8.41M, a 178.42% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for fiscal 2024 was $3.02M, a 69.30% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for fiscal 2023 was $1.78M.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, acquisitions for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2026-06-30 | $4.27M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $8.41M 10-K · filed 2026-03-03 |
| 2025-09-30 | $8.41M 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $3.02M 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.02M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.02M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $3.02M 10-Q · filed 2025-05-12 | $3.02M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.78M 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2023-03-31 | $1.78M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |